Person › Details

Carl-Ake Carlsson (Xellia Pharmaceuticals ApS)

Carlsson, Carl-Ake (Novo Group 201305 CEO of Xellia Pharmaceuticals)

	Organisation	Xellia Pharmaceuticals ApS
	Group	Novo Group (Group)
	Product	vancomycin (INN)
	Product 2	antibiotic

Record changed: 2015-08-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

Carl-Ake Carlsson (Xellia Pharmaceuticals ApS)